Hidekazu Takahashi Selected Research

Drug Therapy (Chemotherapy)

11/2023	Treatment response prediction of neoadjuvant chemotherapy for rectal cancer by deep learning of colonoscopy images.
10/2023	Cancer Stem Cells Persist Despite Cellular Damage, Emergence of the Refractory Cell Population.
1/2023	A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer.
7/2022	The Geriatric Nutritional Risk Index as a Prognosis Predictor in Patients With Rectal Cancer Receiving Neoadjuvant Chemotherapy.
4/2022	A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202).
1/2022	Successful Radiotherapy of Primary Malignant Peripheral Nerve Sheath Tumor of the Lung.
8/2021	Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma.
3/2021	[Capecitabine and Oxaliplatin(CAPOX)plus Bevacizumab as Second-Line Chemotherapy for Metastatic Colorectal Cancer].
10/2020	Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer.
1/2020	Preoperative imatinib and laparoscopic intersphincteric resection for large rectal gastrointestinal stromal tumor: A case report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidekazu Takahashi Research Topics

Disease

70	Neoplasms (Cancer) 11/2023 - 01/2007
52	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2013
19	Rectal Neoplasms (Rectal Cancer) 11/2023 - 07/2015
18	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2009
12	Inflammation (Inflammations) 04/2023 - 03/2013
11	Colonic Neoplasms (Colon Cancer) 05/2022 - 11/2014
9	Stomach Neoplasms (Stomach Cancer) 04/2024 - 03/2006
7	Crohn Disease (Crohn's Disease) 11/2023 - 03/2017
7	Wounds and Injuries (Trauma) 12/2022 - 11/2005
7	Fatigue 12/2021 - 01/2005
6	Lymphatic Metastasis 10/2022 - 11/2015
5	Carcinogenesis 04/2023 - 09/2012
5	Adenocarcinoma 11/2021 - 01/2013
5	Shock 07/2021 - 01/2016
4	Colitis 10/2023 - 09/2018
4	Hemorrhage 07/2021 - 11/2015
4	Hypertension (High Blood Pressure) 12/2020 - 04/2017
4	Carcinoma (Carcinomatosis) 04/2018 - 03/2006
3	Ulcerative Colitis 03/2022 - 02/2018
3	Triple Negative Breast Neoplasms 11/2019 - 03/2016
3	Hypoxia (Hypoxemia) 02/2018 - 01/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2017 - 05/2014
3	Pain (Aches) 08/2017 - 01/2016
2	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2020
2	Fistula 11/2023 - 07/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2023 - 03/2018
2	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 08/2021
2	Microsatellite Instability 05/2022 - 01/2019
2	Obesity 08/2021 - 04/2017
2	Thrombosis (Thrombus) 07/2021 - 08/2018
2	Heart Failure 07/2021 - 09/2020
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2021 - 10/2017
2	AIDS-Related Complex (ARC) 01/2021 - 06/2006
2	Intestinal Failure 10/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2013
11	MicroRNAs (MicroRNA)IBA 04/2023 - 03/2015
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 11/2014
8	Biomarkers (Surrogate Marker)IBA 08/2021 - 05/2014
6	Capecitabine (Xeloda)FDA Link 01/2023 - 08/2016
5	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2017
5	EnzymesIBA 08/2021 - 11/2016
5	Amino Acids FDA Link 12/2020 - 03/2017
4	carboapatiteIBA 04/2023 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2018 - 02/2013
3	AlbuminsIBA 07/2023 - 01/2019
3	AntigensIBA 05/2023 - 01/2021
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2023 - 09/2018
3	Dextrans (Dextran)FDA Link 04/2023 - 09/2018
3	LigandsIBA 01/2023 - 01/2015
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 01/2018
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 12/2016
3	AnticoagulantsIBA 06/2022 - 08/2016
3	Bevacizumab (Avastin)FDA Link 04/2022 - 03/2021
3	ArginaseIBA 08/2021 - 02/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2009
3	CytokinesIBA 01/2020 - 02/2013
3	Alanine (L-Alanine)FDA Link 01/2019 - 03/2017
3	GlycolipidsIBA 08/2013 - 06/2012
3	Membrane Proteins (Integral Membrane Proteins)IBA 08/2013 - 06/2012
3	MetalsIBA 01/2013 - 03/2004
2	NivolumabIBA 04/2024 - 05/2022
2	Calcibiotic Root Canal SealerIBA 10/2023 - 01/2016
2	CarbohydratesIBA 05/2023 - 01/2023
2	Long Noncoding RNAIBA 05/2023 - 02/2018
2	InterferonsIBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 05/2022 - 12/2017
2	Carcinoembryonic AntigenIBA 05/2022 - 12/2018
2	Indicators and Reagents (Reagents)IBA 05/2022 - 10/2020
2	Coloring Agents (Dyes)IBA 03/2022 - 01/2019
2	InterleukinsIBA 01/2022 - 02/2013
2	ChemokinesIBA 01/2022 - 01/2014
2	Histone MethyltransferasesIBA 01/2022 - 06/2021
2	PolymersIBA 07/2021 - 06/2021
2	Phosphopyruvate Hydratase (Enolase)IBA 07/2021 - 03/2017
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2018
2	Aromatic Amino Acids (Aromatic Amino Acid)IBA 12/2020 - 04/2017
2	Branched-Chain Amino AcidsIBA 12/2020 - 04/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 11/2005
2	AcidsIBA 01/2020 - 09/2012
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 09/2012
2	C-Reactive ProteinIBA 01/2019 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2017

Therapy/Procedure

29	Therapeutics 04/2024 - 03/2006
21	Drug Therapy (Chemotherapy) 11/2023 - 03/2006
11	Colectomy 05/2024 - 11/2016
10	Neoadjuvant Therapy 11/2023 - 01/2007
8	Lymph Node Excision (Lymph Node Dissection) 05/2022 - 11/2015
5	Chemoradiotherapy 11/2023 - 11/2014
5	Adjuvant Chemotherapy 10/2022 - 11/2015
4	Radiotherapy 01/2022 - 12/2010
4	Removable Partial Denture 12/2021 - 01/2016
3	Laparotomy 01/2022 - 09/2017
3	Lasers (Laser) 10/2019 - 01/2016
2	Stents 07/2023 - 08/2018
2	Activities of Daily Living (ADL) 03/2022 - 11/2015
2	Restorative Proctocolectomy 03/2022 - 09/2021
2	Heart-Assist Devices 07/2021 - 09/2017
2	Splints (Splint) 06/2021 - 09/2017
2	Home Parenteral Nutrition 10/2020 - 01/2019
2	Catheters 10/2020 - 07/2019